CUE RSI Chart
Last 7 days
-1.1%
Last 30 days
5.5%
Last 90 days
-21.5%
Trailing 12 Months
-56.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 7.0M | 0 | 0 | 0 |
2023 | 432.0K | 1.8M | 3.8M | 5.5M |
2022 | 14.4M | 11.7M | 9.3M | 1.2M |
2021 | 3.8M | 5.5M | 7.2M | 14.9M |
2020 | 4.0M | 4.0M | 3.7M | 3.2M |
2019 | 1.7M | 2.3M | 2.9M | 3.5M |
2018 | 0 | 0 | 0 | 1.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 25, 2023 | suri anish | bought | 11,040 | 2.76 | 4,000 | president and cso |
Aug 14, 2023 | passeri daniel r | bought | 8,580 | 2.86 | 3,000 | chief executive officer |
Mar 23, 2023 | kiener peter a | sold | -30,586 | 3.28 | -9,325 | - |
Mar 23, 2023 | kiener peter a | acquired | 27,690 | 2.86 | 9,682 | - |
Aug 22, 2022 | millar kerri-ann | sold (taxes) | -8,625 | 3.05 | -2,828 | chief financial officer |
Aug 21, 2022 | millar kerri-ann | acquired | - | - | 6,667 | chief financial officer |
Jun 14, 2022 | gray cameron | sold (taxes) | -164,998 | 3.2 | -51,562 | - |
Jun 14, 2022 | gray cameron | acquired | 165,000 | 2.7 | 61,111 | - |
May 27, 2022 | morich frank | bought | 105,000 | 3.75 | 28,000 | - |
May 24, 2022 | fletcher aaron g.l. | bought | 183,700 | 3.34 | 55,000 | - |
Which funds bought or sold CUE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Tidal Investments LLC | new | - | 21,947 | 21,947 | -% |
May 16, 2024 | COMERICA BANK | added | 37.47 | -62.00 | 3,827 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -144,220 | - | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.92 | -8,799 | 6,838 | -% |
May 15, 2024 | Robertson Stephens Wealth Management, LLC | unchanged | - | -358,875 | 904,365 | 0.05% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -21.75 | -67,720 | 86,255 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -91.97 | -31,000 | 2,000 | -% |
May 15, 2024 | Voya Investment Management LLC | reduced | -7.69 | -13,033 | 25,400 | -% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -42.00 | -1,331 | 945 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 31.36 | -43,353 | 684,350 | -% |
Unveiling Cue Biopharma Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Cue Biopharma Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Cue Biopharma Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -5.7% | 1,717,000 | 1,821,000 | 2,100,000 | 1,382,000 | 187,000 | 151,000 | 68,000 | 26,000 | 1,000,000 | 8,254,370 | 2,395,000 | 2,739,000 | 1,553,000 | 475,325 | 704,000 | 1,075,000 | 900,000 | 1,049,331 | 984,000 | 1,055,000 | 370,000 |
Operating Expenses | -8.1% | 14,385,000 | 15,653,500 | 13,519,000 | 14,899,000 | 13,567,000 | 15,017,000 | 11,099,000 | 13,116,000 | 15,238,000 | 16,137,443 | 15,413,000 | 13,042,000 | 14,071,000 | 11,449,910 | 10,835,000 | 12,017,000 | 13,895,000 | 10,065,578 | 8,078,000 | 10,286,000 | 11,797,000 |
S&GA Expenses | -100.0% | - | 4,609,500 | 3,645,000 | 4,249,000 | 4,176,000 | 3,703,500 | 3,528,000 | 3,782,000 | 5,156,000 | 4,646,678 | 4,125,000 | 4,280,000 | 4,255,000 | 3,446,205 | 3,318,000 | 3,898,000 | 3,989,000 | 3,100,593 | 2,776,000 | 3,419,000 | 3,444,000 |
R&D Expenses | -6.3% | 10,199,000 | 10,887,000 | 9,874,000 | 10,650,000 | 9,391,000 | 11,332,500 | 7,571,000 | 9,592,000 | 10,082,000 | 11,490,765 | 11,288,000 | 8,762,000 | 9,816,000 | 8,003,705 | 7,517,000 | 8,119,000 | 9,906,000 | 6,964,985 | 5,302,000 | 6,867,000 | 8,353,000 |
EBITDA Margin | 21.9% | -7.65 | -9.79 | -14.03 | -29.85 | -123 | -42.41 | -4.60 | -3.66 | -2.95 | -2.84 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | 44.2% | -241,000 | -432,000 | -286,000 | -232,000 | -370,000 | -358,000 | -124,000 | -206,000 | -25,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | 289,000 | - | - | 206,000 | - | - | - | - | -500 | - | 413,000 | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10,896,671 | -10,031,000 | -10,833,000 | - | -8,918,457 | -6,990,000 | -9,109,000 | - |
EBT Margin | 21.8% | -7.55 | -9.66 | -13.88 | -29.65 | -122 | -42.58 | -4.67 | -3.74 | -3.03 | -2.92 | -5.68 | -7.43 | - | - | - | - | - | - | - | - | - |
Net Income | 8.1% | -12,347,000 | -13,434,000 | -11,005,000 | -13,185,000 | -13,109,000 | -14,592,000 | -10,955,000 | -13,208,000 | -14,255,000 | -8,384,175 | -12,993,000 | -10,279,000 | -12,505,000 | -11,102,921 | -10,031,000 | -10,833,000 | -12,818,000 | -8,918,457 | -6,990,000 | -9,522,000 | -11,267,000 |
Net Income Margin | 23.0% | -7.12 | -9.24 | -13.58 | -28.99 | -120 | -42.58 | -5.01 | -4.18 | -3.19 | -2.96 | -6.55 | -8.03 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 10.2% | -9,839,000 | -10,958,000 | -7,799,000 | -10,371,000 | -10,833,000 | -10,515,000 | -6,949,000 | -12,913,000 | -11,600,000 | -10,645,205 | -6,640,000 | -10,022,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -12.3% | 54.00 | 62.00 | 69.00 | 73.00 | 82.00 | 91.00 | 76.00 | 85.00 | 91.00 | 83.00 | 79.00 | 90.00 | 89.00 | 100 | 107 | 101 | 61.00 | 72.00 | 45.00 | 42.00 | 45.00 |
Current Assets | -13.2% | 45.00 | 51.00 | 58.00 | 61.00 | 69.00 | 77.00 | 62.00 | 69.00 | 76.00 | 68.00 | 70.00 | 80.00 | 77.00 | 88.00 | 94.00 | 88.00 | 51.00 | 61.00 | 33.00 | 30.00 | 32.00 |
Cash Equivalents | -15.4% | 41.00 | 49.00 | 55.00 | 53.00 | 56.00 | 52.00 | 30.00 | 66.00 | 68.00 | 64.00 | 68.00 | 74.00 | 73.00 | 75.00 | 72.00 | 60.00 | 23.00 | 44.00 | 31.00 | 24.00 | 22.00 |
Net PPE | -5.2% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 |
Liabilities | -2.2% | 24.00 | 24.00 | 26.00 | 27.00 | 27.00 | 26.00 | 26.00 | 25.00 | 26.00 | 18.00 | 15.00 | 17.00 | 19.00 | 21.00 | 19.00 | 21.00 | 15.00 | 17.00 | 18.00 | 21.00 | 20.00 |
Current Liabilities | 5.9% | 18.00 | 17.00 | 17.00 | 16.00 | 14.00 | 12.00 | 10.00 | 8.00 | 11.00 | 13.00 | 15.00 | 17.00 | 17.00 | 16.00 | 14.00 | 15.00 | 12.00 | 12.00 | 10.00 | 11.00 | 11.00 |
Long Term Debt | -22.8% | 3.00 | 4.00 | 5.00 | 6.00 | 7.00 | 8.00 | 9.00 | 10.00 | 10.00 | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 4.00 | 5.00 | 6.00 | 7.00 | 8.00 | 9.00 | 10.00 | 10.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -19.0% | 30.00 | 37.00 | 43.00 | 46.00 | 55.00 | 66.00 | 51.00 | 60.00 | 65.00 | 65.00 | 64.00 | 73.00 | 70.00 | 79.00 | 88.00 | 80.00 | 45.00 | 55.00 | 27.00 | 20.00 | 25.00 |
Retained Earnings | -4.1% | -313 | -301 | -287 | -276 | -263 | -250 | -235 | -224 | -211 | -197 | -189 | -176 | -165 | -153 | -142 | -132 | -121 | -108 | -99.58 | -92.59 | -83.07 |
Additional Paid-In Capital | 1.6% | 344 | 338 | 330 | 323 | 319 | 316 | 287 | 285 | 276 | 263 | 253 | 249 | 235 | 232 | 230 | 212 | 166 | 163 | 127 | 113 | 108 |
Shares Outstanding | 13.0% | 49.00 | 43.00 | 45.00 | 44.00 | 43.00 | 47.00 | 34.00 | 35.00 | 33.00 | 32.00 | 31.00 | 31.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 154 | - | - | - | 82.00 | - | - | - | 363 | - | - | - | 695 | - | - | - | 160 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 10.7% | -9,784,000 | -10,958,000 | -7,799,000 | -10,371,000 | -10,833,000 | -10,514,000 | -6,871,000 | -12,848,000 | -11,573,000 | -10,645,166 | -6,627,000 | -9,770,000 | -11,795,000 | -6,999,034 | -7,687,000 | -6,864,000 | -10,944,000 | -6,437,910 | -9,208,000 | -6,676,000 | -8,475,000 |
Share Based Compensation | -6.1% | 1,946,000 | 2,072,000 | 2,073,000 | 2,037,000 | 1,998,000 | 2,112,000 | 2,064,000 | 2,309,000 | 3,011,000 | 2,974,084 | 3,252,000 | 2,854,000 | 2,436,000 | 2,281,782 | 2,500,000 | 2,524,000 | 3,175,000 | 1,994,482 | 1,439,000 | 1,321,000 | 1,768,000 |
Cashflow From Investing | -Infinity% | -55,000 | - | 5,000,000 | 5,000,000 | 15,002,000 | 4,999,000 | -29,520,000 | -62,000 | -27,000 | 511 | -11,000 | -233,000 | 9,352,000 | 9,891,874 | 4,654,000 | -140,000 | -9,950,000 | -15,145,177 | 3,984,000 | 5,127,000 | 9,481,000 |
Cashflow From Financing | -50.8% | 2,354,000 | 4,782,000 | 4,589,000 | 2,101,000 | 388,000 | 27,403,000 | -9,000 | 11,109,000 | 15,156,000 | 7,382,322 | 351,000 | 10,666,000 | 834,000 | 244,263 | 15,013,000 | 43,321,000 | 36,000 | 34,493,765 | 12,292,000 | 3,747,000 | 257,000 |
Buy Backs | - | - | - | - | - | - | - | 9,000 | - | 191,000 | 183,128 | 482,000 | - | 85,000 | 160,051 | 35,000 | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Collaboration revenue | $ 1,717 | $ 187 |
Operating expenses: | ||
General and administrative | 4,186 | 4,176 |
Research and development | 10,199 | 9,391 |
Total operating expenses | 14,385 | 13,567 |
Loss from operations | (12,668) | (13,380) |
Other income (expense): | ||
Interest income | 562 | 641 |
Interest expense | (241) | (370) |
Total other income (expense), net | 321 | 271 |
Net loss | (12,347) | (13,109) |
Unrealized gain from available-for-sale securities | 0 | 57 |
Comprehensive loss | $ (12,347) | $ (13,052) |
Net loss per common share, basic | $ (0.25) | $ (0.29) |
Net loss per common share, diluted | $ (0.25) | $ (0.29) |
Weighted average common shares outstanding, basic | 49,466,711 | 44,652,353 |
Weighted average common shares outstanding, diluted | 49,466,711 | 44,652,353 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 41,029 | $ 48,514 |
Accounts receivable | 1,400 | 1,698 |
Prepaid expenses and other current assets | 2,240 | 1,242 |
Total current assets | 44,669 | 51,454 |
Property and equipment, net | 754 | 795 |
Operating lease right-of-use | 5,573 | 6,323 |
Deposits | 2,690 | 2,690 |
Restricted cash | 151 | 151 |
Other long-term assets | 114 | 117 |
Total assets | 53,951 | 61,530 |
Current liabilities: | ||
Accounts payable | 3,919 | 3,501 |
Accrued expenses | 5,208 | 4,137 |
Research and development contract liability, current portion | 1,790 | 2,112 |
Operating lease liabilities, current | 3,210 | |
Current portion of long-term debt, net | 3,963 | 3,963 |
Total current liabilities | 18,090 | 17,081 |
Operating lease liabilities, non-current | 2,579 | |
Long-term debt, net | 3,244 | 4,202 |
Total liabilities | 23,913 | 24,445 |
Commitments and contingencies (Note 11) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.001 par value; 100,000,000 shares authorized; 48,643,316 and 47,215,116 shares issued and outstanding, at March 31, 2024 and December 31, 2023, respectively | 48 | 47 |
Additional paid in capital | 343,527 | 338,228 |
Accumulated deficit | (313,537) | (301,190) |
Total stockholders' equity | 30,038 | 37,085 |
Total liabilities and stockholders' equity | $ 53,951 | $ 61,530 |